JP Morgan resumed coverage on Wave Life Sciences with a new price target
$WVE
Biotechnology: Pharmaceutical Preparations
Health Care
JP Morgan resumed coverage of Wave Life Sciences with a rating of Overweight and set a new price target of $13.00 from $10.00 previously